Results 91 to 100 of about 11,782,455 (235)

Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice

open access: yesScientific Reports, 2017
While gap junctions mediate intercellular communication and support liver homeostasis, connexin hemichannels are preferentially opened by pathological stimuli, including inflammation and oxidative stress.
Joost Willebrords   +15 more
doaj   +1 more source

The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression

open access: yesNature Communications, 2021
Mechanisms that underlie the progression of non-alcoholic fatty liver disease to the more severe non-alcoholic steatohepatitis are incompletely understood.
Xinzhi Li   +11 more
doaj   +1 more source

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients

open access: yesIndian Journal of Pathology and Microbiology, 2010
Background: Alcoholic steatohepatitis (ASH) and non-alcoholic steatohepatitis (NASH) are significant forms of liver disease and may progress to end-stage liver disease, cirrhosis and potentially malignant complications.
Singh Deepak   +4 more
doaj  

The role of blood groups in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

open access: yes, 2017
Introduction: Non-alcoholic fatty liver disease is defined as the accumulation of fat in the liver in the absence of excessive alcohol consumption or other known pathologies and is a spectrum of disease ranging from steatosis (fat infiltration into the ...
Arik, Ferhat   +10 more
core   +1 more source

Postoperative association between impaired renal function and vascular dysfunction in liver transplant recipients

open access: yes, 2022
Liver Transplantation, EarlyView.
Domenico A. Chavez   +8 more
wiley   +1 more source

Quality of life in patients with non-alcoholic steatohepatitis and hypertension: quantitative variability of indicators

open access: yes, 2023
The aim of the study is to determine the impact of concomitant hypertension on the quality of life of patients with non-alcoholic steatohepatitis. Materials and methods: A total of 115 patients with non-alcoholic steatohepatitis (NASH) were examined, 63
Zhelezniakova, Natalia   +1 more
core   +1 more source

Insulin resistance in non-alcoholic steatohepatitis

open access: yes, 2001
Background. Non-alcoholic steatohepatitis is a chronic liver disease that is capable of progressing to end-stage liver disease, but generally has a benign course.
Comert, B   +17 more
core   +1 more source

Answering Pivotal Questions in the Diagnosis and Treatment of Primary Biliary Cirrhosis and Non-Alcoholic Steatohepatitis [PDF]

open access: yes, 2015
Professor Trauner introduced the subject of liver disease and its burden within the European Union (EU) and across the globe. Professor Jones summarised the progress made in understanding the pathophysiology of primary biliary cirrhosis (PBC), current ...
Michael Trauner   +2 more
core  

Alcoholic steatohepatitis

open access: yes, 2010
Severe alcoholic steatohepatitis has a poor prognosis and is characterized by jaundice and signs of liver failure. Its incidence is unknown, but prevalence is around 20% in cohorts of alcoholics undergoing liver biopsy.
Stickel, Felix   +5 more
core   +1 more source

Protective Properties of FOXO1 Inhibition in a Murine Model of Non-alcoholic Fatty Liver Disease Are Associated With Attenuation of ER Stress and Necroptosis

open access: yesFrontiers in Physiology, 2020
AimThe pathogenesis of non-alcoholic fatty liver disease is currently unclear, however, lipid accumulation leading to endoplasmic reticulum stress appears to be pivotal in the process. At present, FOXO1 is known to be involved in NAFLD progression.
Hao-ran Ding   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy